Convalescent plasma therapy for coronavirus disease 2019 in ambulatory versus hospitalized patients: Efficacy and risk of thromboembolism

BACKGROUND: Although early evidence concluded a lack of clinical benefit of convalescent plasma therapy (CPT) in COVID-19 management, recent trials have demonstrated the therapeutic potential of CPT in ambulatory care. CPT may also potentiate thromboembolic events, given the presence of coagulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Pei Ye, Yu, Philip, Li, Allen, Khalid, Faran, Laureano, Marissa Liselle, Crowther, Mark Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901222/
https://www.ncbi.nlm.nih.gov/pubmed/36777286
http://dx.doi.org/10.1016/j.rpth.2023.100068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901222/
https://www.ncbi.nlm.nih.gov/pubmed/36777286
http://dx.doi.org/10.1016/j.rpth.2023.100068

Ejemplares similares